XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 28, 2025
Jun. 29, 2024
Jun. 28, 2025
Jun. 29, 2024
Revenues:        
Total revenues $ 8,454,883 $ 12,336,423 $ 18,993,375 $ 22,369,064
Expenses:        
Cost of product revenues 7,071,517 8,685,328 14,700,984 17,226,902
Research and development 1,945,436 1,839,663 4,061,357 3,940,416
Selling, general and administration 4,899,313 7,267,868 9,600,374 14,499,733
Litigation damages 24,800,000
Total expenses 13,916,266 17,792,859 28,362,715 60,467,051
Loss from operations (5,461,383) (5,456,436) (9,369,340) (38,097,987)
Other income (expense)        
Interest income 326,302 226,677 772,750 399,517
Other (expense) income (10,882) 18,867 314,052 18,824
Loss on impairment of investments, net (858) (734,286) (24,979) (734,286)
Foreign currency transaction gains (losses) 32,188 23,180 131,351 (56,281)
Total other income (expense), net 346,750 (465,562) 1,193,174 (372,226)
Loss before provision for income taxes (5,114,633) (5,921,998) (8,176,166) (38,470,213)
Tax provision (52,000) (104,000)
Net loss $ (5,166,633) $ (5,921,998) $ (8,280,166) $ (38,470,213)
Net loss per share        
Basic $ (0.03) $ (0.05) $ (0.05) $ (0.32)
Diluted $ (0.03) $ (0.05) $ (0.05) $ (0.32)
Weighted average number of common shares outstanding        
Basic 166,351,615 121,400,739 166,234,813 120,757,868
Diluted 166,351,615 121,400,739 166,234,813 120,757,868
Net Product Revenues [Member]        
Revenues:        
Total revenues $ 7,498,436 $ 11,054,030 $ 16,728,321 $ 20,079,396
Research and Development Revenues [Member]        
Revenues:        
Total revenues 907,907 1,170,329 2,144,574 2,070,294
License and Other Revenues [Member]        
Revenues:        
Total revenues $ 48,540 $ 112,064 $ 120,480 $ 219,374